IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab…
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha…
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
China International College Students’ Innovation Competition 2025 Finals Conclude in Zhengzhou
ZHENGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- In a report published by Xinhua…
CoinLander Launches RWA Platform, Unlocking Stable Returns from Tokenized Real Estate Mortgages
Platform Democratizes Access to Real-World Asset (RWA) Investments, Merging Tangible Security with…
HTX Launches the “Sail Together” Initiative, Airdropping 100 Million USDT to Help Global Traders Weather Market Turbulence
PANAMA CITY, Oct. 20, 2025 /PRNewswire/ -- Rocked by the sudden "black swan…
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
Missed out on gold and Bitcoin? RWA is creating a new batch of multi-millionaires!
London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As global markets face…
From Economic Turbulence to a New Era of Wealth: NB HASH RWA Brings Real-World Assets On-Chain for Stable Digital Growth
London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As global markets face…
From Inflation to Innovation: How NB HASH and RWA Are Powering the Next Digital Wealth Boom
London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As inflation pressures mount…
